Sign Up to like & get
recommendations!
2
Published in 2023 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.18932
Abstract: Although ocular adverse events are frequent in AD patients treated with dupilumab, their characterization remains limited due to a lack of prospective studies with a systematic ophthalmological examination.
read more here.
Keywords:
multicenter prospective;
induced ocular;
observational study;
study dupilumab ... See more keywords